These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5641512)

  • 1. Distribution of 14C-labeled 8-methyl ether of xanthurenic acid in the mouse following bladder luminal, subcutaneous, and intraperitoneal administration under carcinogenic conditions.
    Bryan GT; Morris CR
    Cancer Res; 1968 Feb; 28(2):186-91. PubMed ID: 5641512
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of the 8-methyl ether of xanthurenic acid in the mouse.
    Lower GM; Bryan GT
    Cancer Res; 1969 May; 29(5):1013-8. PubMed ID: 5781093
    [No Abstract]   [Full Text] [Related]  

  • 3. Pellet implantation studies of carcinogenic compounds.
    Bryan GT
    J Natl Cancer Inst; 1969 Jul; 43(1):255-61. PubMed ID: 5796388
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption of 14 C-labeled 3-hydroxy-L-kynurenine and 3-hydroxyanthranilic acid from the mouse urinary bladder under carcinogenic conditions.
    Bryan GT; Morris CR; Brown RR
    Cancer Res; 1965 Oct; 25(9):1432-7. PubMed ID: 5861071
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the role of tryptophan metabolites in the genesis of bladder cancer.
    Wolf H
    Acta Chir Scand Suppl; 1973; 433():154-68. PubMed ID: 4513505
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method to determine urinary quinoline compounds in patients with bladder cancer.
    Fujinaga T; Nakamura J; Sangen H; Ohkawa T; Kido R
    Invest Urol; 1980 Mar; 17(5):416-8. PubMed ID: 7358505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplastic response of various tissues to the systemic administration of the 8-methyl ether of xanthurenic acid.
    Bryan GT
    Cancer Res; 1968 Feb; 28(2):183-5. PubMed ID: 5641511
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic formation of xanthurenic acid 8-methyl ether, an endogenous carcinogen, in animal tissues.
    Suzuki M; Tabara M; Iinuma F; Watanabe M
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2340-5. PubMed ID: 6435892
    [No Abstract]   [Full Text] [Related]  

  • 10. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. II. Absorption, distribution, metabolism and excretion of 1- 14C-acetohydroxamic acid.
    Fishbein WN; Streeter CL; Daly J
    J Pharmacol Exp Ther; 1973 Jul; 186(1):173-82. PubMed ID: 4723309
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of the 8-methyl ether of xanthurenic acid in the rabbit.
    Lower GM; Bryan GT
    J Biol Chem; 1969 May; 244(10):2567-71. PubMed ID: 5769991
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism and binding of ( 14 C)mycophenolic acid in the rat.
    Nery R; Nice E
    J Pharm Pharmacol; 1971 Nov; 23(11):842-7. PubMed ID: 4400192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems relating to the use of radioactively labelled bacteria in animal experiments. 3. Distribution of activities in mice, following parenteral administration of Pasteurella multocida labeled with various radionuclides].
    Flossmann KD; Hubald J; Müller G
    Arch Exp Veterinarmed; 1980; 34(4):555-64. PubMed ID: 7447600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiation induced xanthurenic acid excretion of white rats and its modification by serotonin and histamine].
    Ladner HA; Wollschläger G
    Strahlentherapie; 1966 Nov; 131(3):461-72. PubMed ID: 5998305
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood and urinary clearance of exogenous serotonin labeled with 14C in relation to the time and route of its administration.
    Modzelewski T; Wojtowicz Z
    Acta Med Pol; 1970; 11(1):29-35. PubMed ID: 5449384
    [No Abstract]   [Full Text] [Related]  

  • 16. The disposition of the anti-inflammatory agent 14C-1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetohydroxamic acid (oxametacine) in the rat.
    Elsom LF; Chasseaud LF; Ray J; Hawkins DR
    Arzneimittelforschung; 1979; 29(8):1155-60. PubMed ID: 583015
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of exogenous serotonin labeled with 14C in the liver of rats in relation to the route and time of its administration.
    Modzelewski T
    Acta Med Pol; 1970; 11(1):37-41. PubMed ID: 5449385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.